Endothelin-1 vasoconstriction and the age-related decline in endothelium-dependent vasodilatation in men

Clinical Science

Volumn 120, Issue 11, 2011, Pages 485-491

  Westby, Christian M ^a   Weil, Brian R ^a   Greiner, Jared J ^a   Stauffer, Brian L ^a,b,c   DeSouza, Christopher A ^a,b  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^c DENVER HEALTH MEDICAL CENTER   (United States)

Author keywords

Aging; Blood flow; Endothelial function; Endothelin; Forearm blood flow; Vasodilatation

Indexed keywords

ACETYLCHOLINE; CLINALFA; CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); ENDOTHELIN 1; HIGH DENSITY LIPOPROTEIN; NITROPRUSSIDE SODIUM; UNCLASSIFIED DRUG;

ADULT; AGE DETERMINATION; AGED; ARTICLE; BODY COMPOSITION; CONTROLLED STUDY; DRUG ACTIVITY; ENDOTHELIUM; FOREARM BLOOD FLOW; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PRIORITY JOURNAL; VASOCONSTRICTION; VASODILATATION;

ACETYLCHOLINE; ADULT; AGING; ANTHROPOMETRY; ENDOTHELIN-1; ENDOTHELIUM, VASCULAR; FOREARM; HUMANS; MALE; MIDDLE AGED; NITROPRUSSIDE; PEPTIDES, CYCLIC; RECEPTORS, ENDOTHELIN; REGIONAL BLOOD FLOW; VASOCONSTRICTION; VASODILATION; VASODILATOR AGENTS; YOUNG ADULT;

EID: 79952344718     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20100475     Document Type: Article

References (41)

1. Lakatta, E.G. and Levy, D. (2003) Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part I: aging arteries: a 'set up' for vascular disease. Circulation 107, 139-146
2. Cernacek, P., Stewart, D.J., Monge, J.C. and Rouleau, J.L. (2003) The endothelin system and its role in acute myocardial infarction. Can. J. Physiol. Pharmacol. 81, 598-606
3. Shimokawa, H. (1999) Primary endothelial dysfunction: atherosclerosis. J. Mol. Cell. Cardiol. 31, 23-37
4. Taddei, S., Virdis, A., Mattei, P., Ghiadoni, L., Fasolo, C.B., Sudano, I. and Salvetti, A. (1997) Hypertension causes premature aging of endothelial function in humans. Hypertension 29, 736-743 (Pubitemid 27097978)
5. DeSouza, C.A., Shapiro, L.F., Clevenger, C.M., Dinenno, F.A., Monahan, K.D., Tanaka, H. and Seals, D.R. (2000) Regular aerobic exercise prevents and restores age-related declines in endothelium-dependent vasodilation in healthy men. Circulation 102, 1351-1357
6. Taddei, S., Virdis, A., Mattei, P., Ghiadoni, L., Gennari, A., Fasolo, C.B., Sudano, I. and Salvetti, A. (1995) Aging and endothelial function in normotensive subjects and patients with essential hypertension. Circulation 91, 1981-1987
7. Taddei, S., Virdis, A., Ghiadoni, L., Salvetti, G., Bernini, G., Magagna, A. and Salvetti, A. (2001) Age-related reduction of NO availability and oxidative stress in humans. Hypertension 38, 274-279 (Pubitemid 34224757)
8. Donato, A.J., Eskurza, I., Silver, A.E., Levy, A.S., Pierce, G.L., Gates, P.E. and Seals, D.R. (2007) Direct evidence of endothelial oxidative stress with aging in humans: relation to impaired endothelium-dependent dilation and upregulation of nuclear factor-?B. Circ. Res. 100, 1659-1666
9. Csiszar, A., Wang, M., Lakatta, E.G. and Ungvari, Z. (2008) Inflammation and endothelial dysfunction during aging: role of NF-?B. J. Appl. Physiol. 105, 1333-1341
10. Kelly, J.J. and Whitworth, J.A. (1999) Endothelin-1 as a mediator in cardiovascular disease. Clin. Exp. Pharmacol. Physiol. 26, 158-161
11. Touyz, R.M. and Schiffrin, E.L. (2003) Role of endothelin in human hypertension. Can. J. Physiol. Pharmacol. 81, 533-541
12. Dashwood, M.R. and Tsui, J.C. (2002) Endothelin-1 and atherosclerosis: potential complications associated with endothelin-receptor blockade. Atherosclerosis 160, 297-304 (Pubitemid 34159321)
13. Miyauchi, T. and Masaki, T. (1999) Pathophysiology of endothelin in the cardiovascular system. Annu. Rev. Physiol. 61, 391-415
14. Van Guilder, G.P.,Westby, C.M., Greiner, J.J., Stauffer, B.L. and DeSouza, C.A. (2007) Endothelin-1 vasoconstrictor tone increases with age in healthy men but can be reduced by regular aerobic exercise. Hypertension 50, 403-409 (Pubitemid 47205792)
15. Iglarz, M. and Clozel, M. (2007) Mechanisms of ET-1-induced endothelial dysfunction. J. Cardiovasc. Pharmacol. 50, 621-628
16. Cardillo, C., Campia, U., Kilcoyne, C.M., Bryant, M.B. and Panza, J.A. (2002) Improved endothelium-dependent vasodilation after blockade of endothelin receptors in patients with essential hypertension. Circulation 105, 452-456 (Pubitemid 34141701)
17. American Diabetes Association (2007) Standards of medical care in diabetes - 2007 Diabetes Care 30 (Suppl. 1), S4-S41
18. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). (2002) Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 106, 3143-3421
19. Chobanian, A.V., Bakris, G.L., Black, H.R., Cushman, W.C., Green, L.A., Izzo, Jr, J.L., Jones, D.W., Materson, B.J., Oparil, S.,Wright, Jr, J.T. and Roccella, E.J. (2003) The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA, J. Am. Med. Assoc. 289, 2560-2572
20. Lohman, T.G., Roche, A.F. and Mortorelli, R. (1988), Anthropometric Standardization Reference Manual, Human, Kinetics, Champaign, IL
21. Cardillo, C., Campia, U., Bryant, M.B. and Panza, J.A. (2002) Increased activity of endogenous endothelin in patients with type II diabetes mellitus. Circulation 106, 1783-1787
22. Cardillo, C., Kilcoyne, C.M., Waclawiw, M., Cannon, III, R.O. and Panza, J.A. (1999) Role of endothelin in the increased vascular tone of patients with essential hypertension. Hypertension 33, 753-758 (Pubitemid 29091660)
23. DeSouza, C.A., Clevenger, C.M., Greiner, J.J., Smith, D.T., Hoetzer, G.L., Shapiro, L.F. and Stauffer, B.L. (2002) Evidence for agonist-specific endothelial vasodilator dysfunction with ageing in healthy humans. J. Physiol. 542, 255-262 (Pubitemid 35190287)
24. Yasue, H., Matsuyama, K., Matsuyama, K., Okumura, K., Morikami, Y. and Ogawa, H. (1990) Responses of angiographically normal human coronary arteries to intracoronary injection of acetylcholine by age and segment. Possible role of early coronary atherosclerosis. Circulation 81, 482-490 (Pubitemid 20055956)
25. Vanhoutte, P.M., Shimokawa, H., Tang, E.H. and Feletou, M. (2009) Endothelial dysfunction and vascular disease. Acta Physiol. 196, 193-222
26. Lakatta, E.G. (2008) Arterial aging is risky. J. Appl. Physiol. 105, 1321-1322
27. Mather, K.J., Lteif, A., Steinberg, H.O. and Baron, A.D. (2004) Interactions between endothelin and nitric oxide in the regulation of vascular tone in obesity and diabetes. Diabetes 53, 2060-2066 (Pubitemid 38970755)
28. Verhaar, M.C., Strachan, F.E., Newby, D.E., Cruden, N.L., Koomans, H.A., Rabelink, T.J. and Webb, D.J. (1998) Endothelin-A receptor antagonist-mediated vasodilatation is attenuated by inhibition of nitric oxide synthesis and by endothelin-B receptor blockade. Circulation 97, 752-756 (Pubitemid 28135337)
29. Callera, G.E., Touyz, R.M., Teixeira, S.A., Muscara, M.N., Carvalho, M.H., Fortes, Z.B., Nigro, D., Schiffrin, E.L. and Tostes, R.C. (2003) ETA receptor blockade decreases vascular superoxide generation in DOCA-salt hypertension. Hypertension 42, 811-817 (Pubitemid 37237330)
30. Li, L., Fink, G.D., Watts, S.W., Northcott, C.A., Galligan, J.J., Pagano, P.J. and Chen, A.F. (2003) Endothelin-1 increases vascular superoxide via endothelinA-NADPH oxidase pathway in low-renin hypertension. Circulation 107, 1053-1058 (Pubitemid 36258731)
31. Gryglewski, R.J., Palmer, R.M. and Moncada, S. (1986) Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature 320, 454-456 (Pubitemid 16097810)
32. Seals, D.R., Desouza, C.A., Donato, A.J. and Tanaka, H. (2008) Habitual exercise and arterial aging. J. Appl. Physiol. 105, 1323-1332
33. Shemyakin, A., Bohm, F., Wagner, H., Efendic, S., Bavenholm, P. and Pernow, J. (2006) Enhanced endothelium-dependent vasodilatation by dual endothelin receptor blockade in individuals with insulin resistance. J. Cardiovasc. Pharmacol. 47, 385-390
34. Taner, C.B., Severson, S.R., Best, P.J., Lerman, A. and Miller, V.M. (2001) Treatment with endothelin-receptor antagonists increases NOS activity in hypercholesterolemia. J. Appl. Physiol. 90, 816-820
35. Chen, Z., Peto, R., Collins, R., MacMahon, S., Lu, J. and Li, W. (1991) Serum cholesterol concentration and coronary heart disease in population with low cholesterol concentrations. Br. Med. J. 303, 276-282
36. Kannel, W.B. (1995) Range of serum cholesterol values in the population developing coronary artery disease. Am. J. Cardiol. 76, 69C-77C
37. Lewington, S., Clarke, R., Qizilbash, N., Peto, R. and Collins, R. (2002) Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 360, 1903-1913 (Pubitemid 35472129)
38. Vasan, R.S., Larson, M.G., Leip, E.P., Evans, J.C., O'Donnell, C.J., Kannel, W.B. and Levy, D. (2001) Impact of high-normal blood pressure on the risk of cardiovascular disease. N. Engl. J. Med. 345, 1291-1297
39. Plavnik, F.L., Ajzen, S.A., Christofalo, D.M., Barbosa, C.S. and Kohlmann, Jr, O. (2007) Endothelial function in normotensive and high-normal hypertensive subjects. J. Hum. Hypertens. 21, 467-472
40. Walker, A.E., Eskurza, I., Pierce, G.L., Gates, P.E. and Seals, D.R. (2009) Modulation of vascular endothelial function by low-density lipoprotein cholesterol with aging: influence of habitual exercise. Am. J. Hypertens. 22, 250-256
41. Stauffer, B.L., Westby, C.M., Greiner, J.J., Van Guilder, G.P. and Desouza, C.A. (2009) Sex-Differences in endothelin-1 mediated vasoconstrictor tone in middle-aged and older adults. Am. J. Physiol. Regul. Integr. Comp. Physiol. 298, R261-R265